Management of Postpartum Hemorrhage
Administer tranexamic acid within 3 hours of birth onset alongside immediate uterotonic therapy (oxytocin as first-line), followed by systematic escalation through mechanical tamponade and surgical interventions if bleeding persists. 1
Immediate First-Line Interventions
When postpartum hemorrhage is diagnosed (blood loss >500 mL vaginal delivery or >1000 mL cesarean), initiate the following simultaneously:
Pharmacologic Management
- Oxytocin: First-line uterotonic agent - administer immediately
- Tranexamic acid 1g IV: Give within 3 hours of birth onset (reduces death from bleeding by preventing fibrinolysis). The WOMAN trial demonstrated that early administration (within 3 hours) significantly reduces maternal mortality from hemorrhage 1
- Second dose of tranexamic acid: May repeat 1g IV if bleeding continues after 30 minutes or recurs within 24 hours 1
Physical Maneuvers
- Uterine massage and bimanual compression
- Empty bladder (catheterize if needed)
- Identify cause using the "4 T's" framework: Tone (uterine atony - 70% of cases), Trauma (lacerations, rupture), Tissue (retained placenta), Thrombin (coagulopathy)
Systematic Escalation Algorithm
Step 1: Additional Uterotonics (if oxytocin fails)
- Methylergonovine OR
- Carboprost (15-methyl PGF2α) OR
- Misoprostol 800-1000 mcg (sublingual/rectal)
Step 2: Mechanical Interventions
- Intrauterine balloon tamponade: Bakri balloon or similar device - highly effective for uterine atony when medications fail 2, 3
- Continue while preparing for potential surgical intervention
Step 3: Surgical Management
Progress through these options based on clinical response:
- Uterine compression sutures (B-Lynch, Cho, or Hayman techniques)
- Vascular ligation: Uterine artery ligation, then internal iliac (hypogastric) artery ligation if needed
- Interventional radiology: Uterine artery embolization (when available and patient stable enough for transfer) 2
- Hysterectomy: Definitive treatment when all other measures fail 2, 3
Concurrent Resuscitation
Hemodynamic Support
- Activate massive transfusion protocol early - do not wait for laboratory confirmation
- Two large-bore IV lines
- Crystalloid resuscitation initially
- Transfusion strategy: Use clinical status as primary guide; restrictive approach (Hgb 7-8 g/dL threshold) acceptable only in stable patients without active bleeding 4
- Balanced blood product replacement (1:1:1 ratio of packed RBCs:FFP:platelets in massive hemorrhage)
Monitoring
- Continuous vital signs
- Quantitative blood loss measurement (not visual estimation - consistently underestimates actual loss)
- Serial hemoglobin/hematocrit
- Coagulation parameters (PT/PTT, fibrinogen, platelets)
Critical Timing Considerations
The 3-hour window for tranexamic acid is evidence-based and non-negotiable - the WOMAN trial of over 20,000 women demonstrated mortality benefit only when given within 3 hours of birth 1. After 3 hours, efficacy diminishes significantly.
Common pitfall: Delaying tranexamic acid while attempting multiple uterotonic agents. These should be given concurrently, not sequentially, when hemorrhage is diagnosed.
Special Circumstances
Retained Placenta
- Manual removal indicated if placenta not delivered within 30 minutes AND severe uncontrolled hemorrhage present 5
- Outside specialized facilities: administer tranexamic acid but avoid manual removal unless hemorrhage is severe and uncontrolled (due to infection risk and technical difficulty without adequate analgesia/asepsis) 5
Placenta Accreta Spectrum
- Requires multidisciplinary team including interventional radiology and blood bank
- Hysterectomy often necessary
- Consider preoperative uterine artery balloon catheter placement in planned cases
Protocol-Driven Care
Evidence increasingly supports protocol-driven management over traditional stepwise escalation 4. Institutions should have:
- Written PPH protocols accessible in delivery areas
- Massive transfusion protocols with clear activation criteria
- Designated team roles and communication pathways
- Regular simulation training (improves outcomes) 2
The key to reducing PPH mortality is early recognition, immediate tranexamic acid administration (within 3 hours), aggressive uterotonic therapy, and rapid escalation without hesitation when initial measures fail 1, 3, 4.